Guillermo Deangulo
Pediatric Hematology-Oncology · Miami, FLNPI 1679791370
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $562,005 of the $928,828 with a category attached, or 60.5%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.5%. 2025 is the largest year on record at $259,172, 2.3 times the $111,918 reported in 2019. Among pediatric hematology-oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 606 payments — averaging $1532.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$218K
- United Therapeutics Corporation$215K
- Jazz Pharmaceuticals Inc.$176K
- Amgen$145K
- Servier Pharmaceuticals LLC$75K
- Bioverativ Therapeutics Inc.$61K
- plus $39K from 24 others
Across 22 payments — averaging $3068.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Swedish Orphan Biovitrum AB$25K
- Novartis$19K
- Pfizer$14K
- Octapharma USA, Inc.$10K
What the payments were for
- Consulting fees$262,19228%
- Speaking & faculty fees$562,00561%
- Travel & lodging$91,85510%
- Food & beverage$12,6771%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 151 | $218,159 |
| United Therapeutics Corporation | 29 | $215,318 |
| Jazz Pharmaceuticals Inc. | 107 | $175,544 |
| Amgen | 137 | $144,671 |
| Servier Pharmaceuticals LLC | 60 | $74,569 |
| Bioverativ Therapeutics Inc. | 47 | $61,387 |
| Sanofi-aventis U.S. LLC | 7 | $26,019 |
| Octapharma USA, Inc. | 15 | $9,950 |
| Alkermes, Inc. | 1 | $1,900 |
| Novo Nordisk | 8 | $193 |
| Caris MPI, Inc. | 2 | $168 |
| Pfizer | 5 | $147 |
| Novartis | 6 | $108 |
| Sobi, Inc | 4 | $101 |
| Genentech USA, Inc. | 4 | $86 |
| Bayer | 4 | $82 |
| Astellas Pharma US Inc | 2 | $57 |
| Genetix Biotherapeutics Inc | 1 | $52 |
| HEMA Biologics, LLC | 3 | $51 |
| AstraZeneca | 2 | $49 |
| RARE Disease Therapeutics, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Y-mabs Therapeutics, Inc. | 1 | $23 |
| USWM, LLC | 1 | $22 |
| Springworks Therapeutics, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Emmaus Medical, Inc. | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| BTG International Inc. | 1 | $16 |
| Biomarin Pharmaceutical Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$928,828 in reported general payments places this provider in the 95th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Miami
- Joanna DavisMiami$411K
- Fernando Corrales-MedinaMiami$335K
- Rachel KronenfeldMiami$40K
- Maggie FaderMiami$11K
- Ofelia AlvarezMiami$9K
- Julio BarredoMiami$8K
- Jorge Galvez SilvaMiami$7K
- Ossama MaherMiami$6K
- Sasha InclanMiami$5K
- Ziad KhatibMiami$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.